
### [NCIT:C80280](http://purl.obolibrary.org/obo/NCIT_C80280)
**Label:** Diffuse Large B-Cell Lymphoma, Not Otherwise Specified

**Subclasses:** [NCIT:C8926](http://purl.obolibrary.org/obo/NCIT_C8926) (Recurrent Centroblastic Lymphoma), [NCIT:C8927](http://purl.obolibrary.org/obo/NCIT_C8927) (Refractory Centroblastic Lymphoma), [NCIT:C7249](http://purl.obolibrary.org/obo/NCIT_C7249) (Immunoblastic Lymphoma Post-Transplant Lymphoproliferative Disorder), [NCIT:C7248](http://purl.obolibrary.org/obo/NCIT_C7248) (Centroblastic Lymphoma Post-Transplant Lymphoproliferative Disorder), [NCIT:C8931](http://purl.obolibrary.org/obo/NCIT_C8931) (Stage IV Centroblastic Lymphoma), [NCIT:C45231](http://purl.obolibrary.org/obo/NCIT_C45231) (Diffuse Large B-Cell Lymphoma Unclassifiable), [NCIT:C8137](http://purl.obolibrary.org/obo/NCIT_C8137) (Stage III Adult Immunoblastic Lymphoma), [NCIT:C8930](http://purl.obolibrary.org/obo/NCIT_C8930) (Stage III Centroblastic Lymphoma), [NCIT:C8124](http://purl.obolibrary.org/obo/NCIT_C8124) (Stage II Adult Immunoblastic Lymphoma), [NCIT:C7247](http://purl.obolibrary.org/obo/NCIT_C7247) (Anaplastic Lymphoma Post-Transplant Lymphoproliferative Disorder), [NCIT:C7873](http://purl.obolibrary.org/obo/NCIT_C7873) (Adult Immunoblastic Lymphoma), [NCIT:C7263](http://purl.obolibrary.org/obo/NCIT_C7263) (Thyroid Gland Immunoblastic Lymphoma), [NCIT:C8078](http://purl.obolibrary.org/obo/NCIT_C8078) (Stage I Adult Immunoblastic Lymphoma), [NCIT:C9079](http://purl.obolibrary.org/obo/NCIT_C9079) (Childhood Immunoblastic Lymphoma), [NCIT:C36081](http://purl.obolibrary.org/obo/NCIT_C36081) (Diffuse Large B-Cell Lymphoma Activated B-Cell Type), [NCIT:C4074](http://purl.obolibrary.org/obo/NCIT_C4074) (Centroblastic Lymphoma), [NCIT:C3461](http://purl.obolibrary.org/obo/NCIT_C3461) (Immunoblastic Lymphoma), [NCIT:C36080](http://purl.obolibrary.org/obo/NCIT_C36080) (Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type), [NCIT:C8163](http://purl.obolibrary.org/obo/NCIT_C8163) (Recurrent Adult Immunoblastic Lymphoma), [NCIT:C45219](http://purl.obolibrary.org/obo/NCIT_C45219) (Diffuse Large B-Cell Lymphoma by Gene Expression Profile), [NCIT:C8150](http://purl.obolibrary.org/obo/NCIT_C8150) (Stage IV Adult Immunoblastic Lymphoma), [NCIT:C6916](http://purl.obolibrary.org/obo/NCIT_C6916) (Anaplastic Lymphoma), [NCIT:C8928](http://purl.obolibrary.org/obo/NCIT_C8928) (Stage I Centroblastic Lymphoma), [NCIT:C8929](http://purl.obolibrary.org/obo/NCIT_C8929) (Stage II Centroblastic Lymphoma), 

**Class expressions from DL-Learner:**

- Thing 54.08%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) 37.28%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39821](http://purl.obolibrary.org/obo/NCIT_C39821) (Infiltrating Bladder Lymphoepithelioma-Like Carcinoma))) 37.28%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39820](http://purl.obolibrary.org/obo/NCIT_C39820) (Infiltrating Bladder Urothelial Carcinoma, Microcystic Variant))) 37.28%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39819](http://purl.obolibrary.org/obo/NCIT_C39819) (Infiltrating Bladder Urothelial Carcinoma, Nested Variant))) 37.28%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39818](http://purl.obolibrary.org/obo/NCIT_C39818) (Infiltrating Bladder Urothelial Carcinoma with Trophoblastic Differentiation))) 37.28%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39817](http://purl.obolibrary.org/obo/NCIT_C39817) (Infiltrating Bladder Urothelial Carcinoma with Glandular Differentiation))) 37.28%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39816](http://purl.obolibrary.org/obo/NCIT_C39816) (Infiltrating Bladder Urothelial Carcinoma with Squamous Differentiation))) 37.28%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39815](http://purl.obolibrary.org/obo/NCIT_C39815) (Cellular Congenital Mesoblastic Nephroma))) 37.28%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39814](http://purl.obolibrary.org/obo/NCIT_C39814) (Classic Congenital Mesoblastic Nephroma))) 37.28%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39813](http://purl.obolibrary.org/obo/NCIT_C39813) (SMARCB1 Gene Inactivation))) 37.28%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39812](http://purl.obolibrary.org/obo/NCIT_C39812) (Metanephric Adenofibroma))) 37.28%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39811](http://purl.obolibrary.org/obo/NCIT_C39811) (t(5;11)(q35;q13)))) 37.28%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39810](http://purl.obolibrary.org/obo/NCIT_C39810) (Type 2 Renal Papillary Adenoma))) 37.28%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39809](http://purl.obolibrary.org/obo/NCIT_C39809) (Type 1 Renal Papillary Adenoma))) 37.28%


